Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Procarta Biosystems

Procarta Biosystems

Developing antibacterials through an adaptable DNA-based platform


Presenter:

Andrew Lightfoot, CEO

Procellia

Procellia

Further information to follow


Presenter:

Joanna Vlahpoulou, Director

Resolomics

Resolomics

Resolomics' proprietary technologies can identify specific bioactive lipid mediators that are directly associated with the resolution of inflammation


Presenter:

Jesmond Dalli, Founder

Royal College of Surgeons in Ireland

Royal College of Surgeons in Ireland

The College’s vision is to improve human health through translational medical research, which is informed by bedside problems, and societal and global health challenges


Presenter:

Derek John, Technology Transfer Case Manager

SomaNautix

SomaNautix

Using the unique endoNaut targeting technology to build an innovative precision products company in oncology

Presenter:

Francesca Crawford, CEO

Sulfisca Therapeutics

Sulfisca Therapeutics

Developing a platform technology of mitochondrial-targeted hydrogen sulfide donor small molecules for use as therapeutic agents


Presenter:

Matthew Whiteman, Sulfisca Therapeutics

Surgical Synergy Ltd

Surgical Synergy Ltd

Further information to follow


Presenter:

Mark Hewitt, CEO

TestaVec Ltd

TestaVec Ltd

TestaVec Ltd is developing the first standardised and validated testing framework and technology to certify safety of gene therapy modalities


Presenter:

Mike Themis, Founder, TestaVec

University College London

University College London

UCL Business PLC (UCLB) is a leading technology commercialisation company that supports research and innovations arising from UCL, one of the UK’s top research-led universities


Presenter:

John Kelly, Founder, Epinostix

University of Birmingham

University of Birmingham

Further information to follow


Presenter:

Nick Gostick, Spinout Development Manager

University of Edinburgh

University of Edinburgh

Embedded within the College of Medicine and Veterinary Medicine, the sector specific  team is focused on building high value companies from early stage intellectual property


Presenter:

Manuelle Debunne, University of Edinburgh | Gareth Blades, University of Edinburgh

University of Exeter

University of Exeter

The University of Exeter’s world class research focuses on understanding and tackling fundamental issues facing humankind


Presenter:

Matthew Whiteman, Sulfisca Therapeutics | Nick Stone, Biopsys | John Terry, Neuronostics